Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Evolus, Inc. EOLS
$10.26
-$0.04 (-0.39%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
586681680.00000000
-
week52high
14.34
-
week52low
6.51
-
Revenue
148616000
-
P/E TTM
-6
-
Beta
1.82802700
-
EPS
-1.26000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | 23 июн 2022 г. | |
| Barclays | Equal-Weight | Underweight | 13 мая 2022 г. |
| Barclays | Equal-Weight | Underweight | 12 мая 2022 г. |
| Truist Securities | Buy | Hold | 20 янв 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 03 ноя 2021 г. |
| SVB Leerink | Outperform | Outperform | 19 янв 2023 г. |
| Mizuho | Buy | Buy | 19 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| FARRELL PETER C | A | 11789 | 11789 | 27 янв 2023 г. |
| FARRELL PETER C | A | 43174 | 8293 | 27 янв 2023 г. |
| GILL DAVID N | A | 11789 | 11789 | 27 янв 2023 г. |
| GILL DAVID N | A | 37861 | 8293 | 27 янв 2023 г. |
| BLANK SIMONE | A | 11789 | 11789 | 27 янв 2023 г. |
| BLANK SIMONE | A | 63174 | 8293 | 27 янв 2023 г. |
| Parschauer Karah Herdman | A | 11789 | 11789 | 27 янв 2023 г. |
| Parschauer Karah Herdman | A | 43174 | 8293 | 27 янв 2023 г. |
| Malik Vikram | A | 11789 | 11789 | 27 янв 2023 г. |
| Malik Vikram | A | 77585 | 8293 | 27 янв 2023 г. |
Новостная лента
Evolus, Inc. (EOLS) Q1 2023 Earnings Call Transcript
Seeking Alpha
09 мая 2023 г. в 22:53
Evolus, Inc. (NASDAQ:EOLS ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants David Erickson - VP, IR David Moatazedi - President and CEO Rui Avelar - CMO and Head, Research & Development Sandra Beaver - CFO Conference Call Participants Annabel Samimy - Stifel Marc Goodman - SVB Securities Douglas Tsao - H.C. Wainwright Operator Greetings, and welcome to the Evolus First Quarter 2023 Earnings Conference Call.
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 19:07
Evolus, Inc. (EOLS) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.27 per share a year ago.
Evolus, Inc. (EOLS) Q4 2022 Earnings Call Transcript
Seeking Alpha
08 мар 2023 г. в 21:36
Evolus, Inc. (NASDAQ:EOLS ) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants David Erickson - Vice President of Investor Relations David Moatazedi - President and Chief Executive Officer Rui Avelar - Chief Medical Officer and Head of Research and Development Sandra Beaver - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel, Nicolaus & Company, Inc. Marc Goodman - SVB Securities Douglas Tsao - H.C. Wainwright & Co. Louise Chen - Cantor Fitzgerald & Co. Navann Ty - BNP Paribas Exane Serge Belanger - Needham & Company, LLC Gregory Fraser - Truist Securities, Inc. Uy Ear - Mizuho Securities Co. Operator Greetings, and welcome to the Evolus Fourth Quarter 2022 Earnings Conference Call.
Evolus, Inc. (EOLS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
08 мар 2023 г. в 18:48
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -14.29% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Evolus to Participate in the Barclays Global Healthcare Conference
Business Wire
28 февр 2023 г. в 08:45
NEWPORT BEACH, Calif.--(BUSINESS WIRE)---- $EOLS--Evolus announces that members of its management team will be participating in the Barclays Global Healthcare Conference in Miami Beach, Florida.